Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |

Follow us on Twitter
Epistem Interim Report
View Epistem's Interim Report
to 31 Dec 2009
Click here
GCLP Accreditation for Epistem's Biomarker Division
Epistem's Biomarker Division

Recent GCLP accreditation enables Epistem's Biomarker Division to support the  later clinical phases of drug development.  For further information please click here.
 Share Price
347.5 p
-7.5p change
Last Updated:Fri Jul 30 22:45:56 2010
(15 min delayed share price)